Conflict of Interest Policy

The International Journal of Pharma Insight Studies is committed to ensuring transparency and maintaining the highest ethical standards in scientific research and publication. We require all authors, reviewers, and editors to disclose any potential conflicts of interest that could influence the content or objectivity of submitted manuscripts.

Understanding Conflicts of Interest
A conflict of interest arises when an individual’s personal, financial, commercial, legal, or professional relationships with other organizations or individuals may affect their impartiality in conducting or presenting research. These relationships, whether directly or indirectly linked to the research, can create bias, intentionally or unintentionally, in the interpretation of data, the design of studies, or the presentation of findings.

Examples of potential conflicts of interest include, but are not limited to:

1. Consultancies or advisory roles
2. Employment with an organization that could benefit from the findings
3. Financial interests such as grants, funding, stock ownership, or royalties
4. Paid honoraria or speaking fees
5. Membership in advocacy groups related to the research topic
6. Patents or intellectual property rights that could benefit from the research outcomes

Full Disclosure Requirement
Authors are required to provide a complete disclosure of any relevant financial, professional, or personal interests when submitting their manuscripts. This disclosure is critical to maintain the integrity of the journal’s peer review process and editorial decision-making. Failure to disclose conflicts of interest may result in the manuscript’s rejection or retraction after publication.

Declaration of Conflicts
Authors should clearly state any conflicts of interest in the cover letter accompanying their manuscript submission. The disclosure must also be included within the manuscript, either as part of the acknowledgments or as a separate section titled "Conflict of Interest." This ensures transparency for both the editorial team and readers, allowing them to assess the article’s content with full knowledge of any potential bias.

Disclosure Statement Example
Here is a sample disclosure statement that authors may use as a template:

"In accordance with the policies of the International Journal of Pharma Insight Studies and my ethical obligations as a researcher, I hereby declare that I [have financial, business, or professional interests in] [am a consultant to] [receive funding from] (delete as appropriate) a company or organization that may be influenced by the research presented in this manuscript. I have disclosed these interests fully to the journal and have established an approved plan for managing any potential conflicts arising from my involvement with these entities."

Reviewers and Editors’ Disclosure
Reviewers and editors are also required to disclose any potential conflicts of interest that could affect their objectivity in the review process. If a reviewer feels unable to provide an unbiased review due to a conflict of interest, they must decline the invitation to review. Editors are responsible for ensuring that no manuscript is handled by individuals with a relevant conflict of interest. When necessary, an alternative editor will be assigned to oversee the manuscript’s peer review process.

Management of Conflicts of Interest
The journal’s editorial team will evaluate all disclosed conflicts of interest on a case-by-case basis. If a declared conflict is deemed significant enough to compromise the integrity of the manuscript, the Editor-in-Chief may decide to reject the submission or request revisions. In some cases, a conflict of interest may be managed through transparency, with the conflict disclosed in the published article. All decisions regarding conflicts of interest are made in the best interest of maintaining scientific credibility and trustworthiness.